Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have heme binding activity and monooxygenase activity. Predicted to be involved in several processes, including epoxygenase P450 pathway; exogenous drug catabolic process; and xenobiotic metabolic process. Predicted to localize to cytoplasm and intracellular membrane-bounded organelle. Human ortholog(s) of this gene implicated in several diseases, including eosinophilic esophagitis; glucose metabolism disease (multiple); multiple myeloma; sickle cell anemia; and warfarin resistance. Orthologous to human CYP2C19 (cytochrome P450 family 2 subfamily C member 19) and CYP2C9 (cytochrome P450 family 2 subfamily C member 9).